Top compounds associated with response to CT62


Feature Type Standardized
Nominal ANOVA
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.03 0.4
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA SJ-172550 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC -0.046 0.4
mRNA PF-543 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.027 0.4
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.041 0.4
Download CSV